Floatz logo

Etanidazole

Adult Anaplastic Oligodendroglioma

National Cancer Institute (NCI)Small moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Adult Anaplastic Oligodendroglioma cohort.

Asset / SponsorPhaseRating
Cediranib
National Cancer Institute (NCI)
Phase 2BBB
Irinotecan
City of Hope Medical Center
Phase 2BB
gsk1120212
Novartis Pharmaceuticals
Phase 4BB
Carboplatin
Oliver Jonas
Phase 2BB
Dabrafenib
Novartis Pharmaceuticals
Phase 4BB

View all 50 →

Same molecule, other indications

Etanidazole is also rated in:

adult anaplastic ependymomaDormant
D
Indicative ·
30 / 100
View asset →
diffuse astrocytomaDormant
D
Indicative ·
30 / 100
View asset →
anaplastic astrocytomaDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →